MedPath

Thrombophilia Screening After Severe IUGR

Recruiting
Conditions
Thrombophilia
IUGR
Pregnancy Complications
Registration Number
NCT05551078
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women over 18 years old
  • Pregnant women
  • IUGR defined by an EFW <3rd centile
  • IUGR before 25 GW
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of positive's thrombophilia screening5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Matthieu Dap

🇫🇷

Nancy, France

Matthieu Dap
🇫🇷Nancy, France
Matthieu Dap
Contact
0630736896
m.dap@chru-nancy.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.